Description
This assay uses the Luminex® 200™ platform.
Consider this assay for a focused analysis of 12 unique human cytokines and chemokines. The Human Cytokine/Chemokine Panel 4 12-Plex Discovery Assay® Array (HDIV12) includes specialized biomarkers such as IL-24, IL-28B, HMGB1, and YKL40, offering insights into specific immune and inflammatory pathways.
This panel is particularly valuable for studying conditions where these biomarkers play a critical role, such as autoimmune diseases, chronic inflammation, and cancer. For example, IL-28B and IL-35 are involved in immune modulation and inflammatory responses, while HMGB1 is a key player in cellular stress and inflammation.
With its targeted selection, this Human Cytokine/Chemokine Panel 4 12-Plex Discovery Assay® provides detailed information on a narrower set of biomarkers, allowing for precise analysis from small sample volumes. HMGB1 can be measured in serum and plasma samples only.
Click here for information on shipping biological samples for Discovery Assays
Published Research Featuring Our HDIV12:
- Kunkel, D., Parker, M., Pearce, R. A., Sanders, R. D., & Lennertz, R. C. (2023). Plasma HMGB1 levels in postoperative delirium. British Journal of Anaesthesia, 130(5), e449–e451.
- Hindle, S., Girard, S., Cote, H. C. F., Money, D., Mann, E., & Boucoiran, I. (2024). Circulating levels of inflammatory mediators in pregnant people living with HIV according to antiretroviral therapy regimen. Frontiers in Microbiology, 14, Article 1282291.